發(fā)布時間：2018-05-26 22:19

  本文選題：慢病毒 + 載體　； 參考：《瀘州醫(yī)學院》2012年碩士論文

【摘要】：目的:本實驗用PCR法擴增出的Trail基因引入慢病毒載體系統(tǒng)，生產Trail慢病毒顆粒并進行病毒滴度檢測。方法:1.Trail基因的獲得：根據GenBank中大鼠Trail基因序列(NM145681.1)，設計出該基因的特異性引物Trail-Agel-F和Trail-Agel-R，并且使用Agel酶的切位點。用PCR法從大鼠cDNA文庫中擴增出目的基因。2.重組質粒的構建：采用In-Fusion技術，將酶切回收后的PCR產物線性交換連接入Agel酶切的真核表達載（GV218），產生目的重組質粒。連接產物質粒轉化大腸桿菌DH5a感受態(tài)細胞，擴增目的重組質粒。3.連接產物的酶切鑒定：收集擴增后的連接產物，酶切后經電泳發(fā)現得到片段長度均與預期相符，基因測序結果亦正確，從而證明克隆Trail基因已成功。4.重組質粒轉染293T細胞：用脂質體Lipofeetamine2000包裹構建的重組質粒和輔助包裝載體，，三質粒共同轉染293T細胞，產生含有表達Trail蛋白的Lentivirus病毒顆粒。5.病毒檢測：重組質粒轉入293T細胞,熒光顯微鏡下觀察GFP的表達，行Western blot鑒定及使用Real-time定量PCR法檢測病毒滴度。結果:成功得到Trail目的基因，重組質粒測序結果與GenBank中Trail基因序列(NM145681.1)比較，證實Trail基因序列正確；三質粒轉染293T細胞后熒光顯微鏡觀察到綠色熒光；WesternBlot檢測觀察到58KD附近處有特征條帶，其大小和目的基因融合蛋白相吻合；孔稀釋法及實時熒光定量PCR病毒滴度測定法測定結果為2E十8TU/ml。結論:成功克隆大鼠Trail基因和成功構建慢病毒載體系統(tǒng)并檢測其滴度。為后續(xù)把有殺滅腫瘤的基因（Trail）轉導進神經干細胞奠定基礎。
[Abstract]:Aim: the Trail gene amplified by PCR method was introduced into the lentivirus vector system to produce Trail lentivirus particles and to detect the virus titer. Methods: 1. Obtaining the gene of Trail: according to the sequence of rat Trail gene NM145681.1 in GenBank, we designed the specific primers Trail-Agel-F and Trail-Agel-Rand used the restriction site of Agel. The target gene. 2. 2 was amplified from rat cDNA library by PCR. Construction of recombinant plasmid: by using In-Fusion technique, the recovered PCR products were linearly exchanged into the eukaryotic expression of Agel digested with GV218G, and the target recombinant plasmid was produced. The recombinant plasmid was transformed into Escherichia coli DH5a competent cells and the target recombinant plasmid was amplified. Identification of ligation products by enzyme digestion: the ligation products were collected and amplified. The results of electrophoresis showed that the length of the ligand fragments were in accordance with the expected results, and the sequencing results were correct, which proved that the cloned Trail gene had been successfully cloned. 4. The recombinant plasmid was transfected into 293T cells: the recombinant plasmid and the auxiliary package vector were constructed by liposome Lipofeetamine2000. The three plasmids were co-transfected into 293T cells to produce Lentivirus virus particles. 5. Virus detection: the recombinant plasmid was transferred into 293T cells. The expression of GFP was observed under fluorescence microscope. Western blot identification and Real-time quantitative PCR assay were used to detect the titer of the virus. Results: the target gene of Trail was successfully obtained, and the sequence of the recombinant plasmid was compared with the sequence of Trail gene in GenBank (NM145681.1), which confirmed that the sequence of Trail gene was correct. After the transfection of the three plasmids into 293T cells, the Western blot analysis showed that there were characteristic bands near 58KD, the size of which was consistent with the target gene fusion protein. The results of pore dilution method and real-time quantitative PCR titer assay were 2e + 8TU / ml. Conclusion: the rat Trail gene was cloned and the lentivirus vector system was successfully constructed and its titer was detected. To lay the foundation for the subsequent transduction of tumor killing gene Trail into neural stem cells.
【學位授予單位】：瀘州醫(yī)學院
【學位級別】：碩士
【學位授予年份】：2012
【分類號】：R392-33

【相似文獻】

相關期刊論文 前10條

1 韓麗輝,馬春紅,孫汶生;TRAIL在腫瘤治療中的研究進展[J];國外醫(yī)學.腫瘤學分冊;2001年03期

2 劉征波;TRAIL系統(tǒng)與細胞凋亡[J];國外醫(yī)學.生理.病理科學與臨床分冊;2003年02期

3 馬正宇;TNF家族新成員TRAIL及其受體與細胞凋亡[J];國外醫(yī)學.分子生物學分冊;1999年03期

4 韓麗輝;TRAIL抗癌作用的分子機制[J];腫瘤學雜志;2002年02期

5 梁建華;TRAIL誘導腫瘤細胞凋亡及藥物干預研究[J];國外醫(yī)學.外科學分冊;2003年04期

6 莊國洪;以TRAIL為靶點的腫瘤生物治療研究[J];中國腫瘤生物治療雜志;2003年02期

7 楊芳,劉紅巖,徐維明,肖紅劍,龍海亭,李s

本文編號：1939151